Similar case studies

REF impact found 18 Case Studies

Currently displayed text from case study:

Identification of novel effects of long wavelength UV (UVA) leads to updated evaluation of health risks and improved approaches to protection

Summary of the impact

New research at Lancaster on the biological effects of UVA radiation has generated three main impacts, first resulting in a leading sun cream manufacturer (Boots Ltd. PLC) to re-evaluate its product development process to account for UVA exposure. Second, the research was one of the key drivers of a recent re-assessment of the validity of the UV index by a working group acting for the World Health Organization (WHO) and the International Commission on Non-Ionizing Radiation Protection (ICNIRP). Finally, the research has been used in public education related to sun protection and the use of tanning beds through both direct engagement with the media and work with North West Cancer Research.

Submitting Institution

Lancaster University

Unit of Assessment

Allied Health Professions, Dentistry, Nursing and Pharmacy

Summary Impact Type

Technological

Research Subject Area(s)

Medical and Health Sciences: Clinical Sciences, Immunology, Oncology and Carcinogenesis

Development of conditionally immortalised cell lines as novel cell models of disease and for cell transplantation

Summary of the impact

Research by Professor Parmjit Jat (first at the Ludwig Institute for Cancer Research, then part of UCL; later at the UCL Institute of Neurology) established and applied the critically important scientific concept of conditional immortalisation to a wide variety of cell lines, enabling cells to be grown indefinitely in vitro but differentiate upon altering the growth conditions. Two companies were established in partnership with Jat to exploit this research, ReNeuron (now worth £63.5m and publicly traded on the London AIM market) and XCellSyz (now part of Lonza AG). More than 20 patents based on Professor Jat's work have been issued. Reagents based on his research have been evaluated, licensed and used by 17 companies worldwide: Amgen, Amylin, Boehringer Mannheim, Cell Genesys, Chiron, Eli Lilly, Genentech Inc., Genetics Institute, Immunex, Johnson & Johnson, Medarex, Novartis, Ortho Pharm., Pfizer Inc., Regeneron, ReNeuron, Takeda, EMD Serono, and XCellSyZ/Cambrex Bioscience/Lonza.

Submitting Institution

University College London

Unit of Assessment

Psychology, Psychiatry and Neuroscience

Summary Impact Type

Technological

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology
Medical and Health Sciences: Oncology and Carcinogenesis

Scientific discoveries in skin pigmentation contribute to the development of best-selling skincare products of high commercial value

Summary of the impact

Ground breaking and unique research carried out at the Centre for Skin Sciences at the University of Bradford has led to the realization of commercial opportunities in two very high-value consumer brands. Technologies developed in collaboration with multi-national personal-care and cosmetic companies for the treatment of skin hyper-pigmentation have been launched on the market and have reached thousands of consumers. The first product launched by Alliance-Boots (April 2012) is sold within the UK's premier skincare range (No. 7). Success in Britain led to its launch in the US, Finland and Thailand. A second product within the Diorsnow range has been launched by Parfum Dior — a branch of LVMH Moët Hennessy • Louis Vuitton S.A.

Submitting Institution

University of Bradford

Unit of Assessment

Allied Health Professions, Dentistry, Nursing and Pharmacy

Summary Impact Type

Technological

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology
Medical and Health Sciences: Clinical Sciences

Improved efficiency for derivation of mouse embryonic stem cells: reducing use of animals and saving costs in life sciences

Summary of the impact

Mouse disease models provide an invaluable tool to the medical sciences, underpinning the understanding of disease mechanisms and the development of therapeutic interventions. A new cultivation protocol for deriving mouse embryonic stem (ES) cells was developed by Dr Nichols between 2006 and 2009. This has facilitated the production of ES cells from disease model mice that can be manipulated in vitro and used to establish modified transgenic mice with the required genetic profile, in a single generation. This method reduces the number of mice needed, as well as associated costs and staff time, by 90%. Dr Nichols has trained industry delegates from international transgenics companies and transgenic facility managers in the new technology. As a consequence, a minimum of 26820 fewer mice have been used in experiments, and a minimum of £536k have been saved since 2009.

Submitting Institution

University of Cambridge

Unit of Assessment

Biological Sciences

Summary Impact Type

Technological

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology, Genetics
Technology: Medical Biotechnology

15: Opening up the opportunities for stem cell therapies for neurodegenerative diseases

Summary of the impact

Neural stem cells offer enormous therapeutic potential for stroke but they require regulatory approval. Researchers at King's College London (KCL) devised a technology to immortalise stem cells, generated clinical-grade neural stem cell lines and demonstrated efficacy in an animal model of stroke. KCL research underpins the first approvals in the UK for a therapeutic stem cell product. This led to an industry-sponsored clinical trial of a stem cell therapeutic that has demonstrated vital improvement in all the first five stroke patients treated. KCL research has made a significant impact by considerably reducing the timetable for delivering potential therapies which will affect the life sciences industry and the process now in place acts as a model for other technology developments in this area.

Submitting Institution

King's College London

Unit of Assessment

Psychology, Psychiatry and Neuroscience

Summary Impact Type

Health

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology
Technology: Medical Biotechnology
Medical and Health Sciences: Neurosciences

06_A portfolio of stem cell culture products is sold worldwide.

Summary of the impact

Impact on commerce: Five stem cell culture products derived from UoE research have been brought to a global market since 2009 through the US based company StemCells Inc. StemCells Inc strategically acquired Stem Cell Sciences plc (SCS), with its licensed portfolio of UoE patents, to position themselves as a world leader in cell-based medicine. This enabled them to develop media and reagent tools in order to pursue nearer-term commercial opportunities. These products include the gold standard media for embryonic stem cell culture, iSTEM.

Beneficiaries: Commercial companies and users of the stem cell culture products.

Significance and Reach: iSTEM is the gold standard media used worldwide by researchers for maintaining mouse ES cells in their basal, non-differentiated state. Products are sold worldwide through global life sciences companies.

Attribution: All research was carried out at UoE between 1994 and 2006 (published up to 2008), led by Prof Austin Smith. Collaboration with Prof Philip Cohen, University of Dundee, on one paper (2008).

Submitting Institution

University of Edinburgh

Unit of Assessment

Biological Sciences

Summary Impact Type

Technological

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology, Genetics

Identification of the genetic basis of inherited keratin skin disorders leading to advances in diagnosis for patients.

Summary of the impact

Keratins are major cytoskeletal proteins of epithelial cells. Pioneering research at the University of Dundee led by Prof Irwin McLean FRSE and Prof Birgit Lane FRSE showed the association of keratin mutations with genetic skin fragility disorders. This has dramatically changed the diagnosis of inherited skin disorders and has directly translated into improved clinical management of patients both in the UK and internationally. Further work on this disease has resulted in the first clinical trial using siRNA for a skin condition.

Submitting Institution

University of Dundee

Unit of Assessment

Biological Sciences

Summary Impact Type

Health

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology

Establishment, commercialisation, and impact of unique pancreatic derived clonal beta cells for end users in the global biopharmaceutical industry and international research community

Summary of the impact

Fundamental to effective treatment of diabetes is the understanding of complex mechanisms regulating the function and demise of insulin-secreting pancreatic beta-cells. Inherent limitations relating to pancreatic beta-cell supply coupled with short functional life in culture prompted the challenge to establish model clonal human beta-cells. Ulster exploited an innovative approach to first establish clonal rodent beta-cells. Further development of our novel technology resulted in the generation, patent protection, and commercialisation of world-first electrofusion-derived functional human beta-cells. Our unique and valuable beta-cell lines have been licensed to multi-national pharmaceutical companies for diabetes drug development and further commercialised by sales through ECACC (now Public Health England) to directly impact on both bio-industry and the international research community by providing a limitless supply of high quality model beta-cells for translational research and diabetes drug development.

Submitting Institution

University of Ulster

Unit of Assessment

Allied Health Professions, Dentistry, Nursing and Pharmacy

Summary Impact Type

Health

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology
Medical and Health Sciences: Clinical Sciences, Immunology

The UK’s first commercial source of cultured skin cells for difficult to manage burns patients

Summary of the impact

Research from the Department of Materials Science and Engineering led to healthcare impact through treatment of burns patients and those with chronic non-healing wounds using the culture and expansion of the patient's own skin cells. This impact was achieved by establishing a product, MySkin®, as the UK's first and only commercially available complete service for the culture and delivery of patient's skin cells. It is now used in 11 out of the UK's 12 major burns units for patients in danger of death from extensive burns. MySkin® benefits patients, clinicians and nurses and was Biomedical Product of the Year in 2008 (see Sky News video (2008) on www.Ilika.com).

Submitting Institution

University of Sheffield

Unit of Assessment

Electrical and Electronic Engineering, Metallurgy and Materials

Summary Impact Type

Technological

Research Subject Area(s)

Medical and Health Sciences: Clinical Sciences

A new process for producing biologically active growth factors: commercial uses for stem cell applications

Summary of the impact

Stem cells play an important role in drug discovery and development of therapeutic interventions. Differentiation (and maintenance) of stem cells into specialised cells is achieved by controlled application of specific, expensive growth factors.

Dr Hyvönen has developed an efficient method for producing highly purified, bioactive human growth factors from E.coli, reducing costs by up to 10-FOLD. tHE TECHNOLOGY HAS BEEN LICENSED TO A major international manufacturer of growth factors (PeproTech Inc.), and to a UK-based specialist stem cell company (CellGS Ltd), enabling them to implement new products and business strategies. Through a departmental facility, material is also being sold to external companies and Cambridge Stem Cell Consortium members. In addition, Dr Hyvönen has made his expertise available to biotech companies through consultancy.

Submitting Institution

University of Cambridge

Unit of Assessment

Biological Sciences

Summary Impact Type

Technological

Research Subject Area(s)

Biological Sciences: Biochemistry and Cell Biology

Filter Impact Case Studies

Download Impact Case Studies